Please assess the completion status of the following clinical trial:

Trial Title: Evaluation of the Efficacy and Safety of Silodosin in the Treatment of the Signs and Symptoms of BPH

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Males in good general health and at least 50 years of age, with symptoms of moderate to severe Benign Prostatic Hyperplasia~Exclusion Criteria:~* Medical conditions that would confound the efficacy evaluation~* Medical conditions in which it would be unsafe to use an alpha-blocker~* Use of concomitant drugs that would confound the efficacy evaluation~* Use of concomitant drugs that would be unsafe with this alpha-blocker

- Gender: MALE
- Minimum Age: 50 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Silodosin (Type: EXPERIMENTAL): None
- Tamsulosin (Type: ACTIVE_COMPARATOR): None
- Placebo (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).